LAKENARINE RAMNAUTH: Open Payments
NPI 1255877908 · JAMAICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$204 in 8 payments from 4 companies in 2025. Trend: 2023 $201 · 2024 $187 · 2025 $204
Food & beverage: $204
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, ABILIFY MAINTENA, COBENFY.
Industry payments across NY — which companies pay providers there.
